case report | Q2782326 |
scholarly article | Q13442814 |
P2093 | author name string | Angela Berardinelli | |
Silvia Salvatore | |||
Alessandro Salvatoni | |||
Massimo Agosti | |||
Paola Cianci | |||
Alex Moretti | |||
Maddalena Marinoni | |||
P2860 | cites work | Intravenous immunoglobulin: adverse reactions and management | Q37289504 |
Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition | Q37714082 | ||
Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients | Q38042583 | ||
Childhood chronic inflammatory demyelinating polyradiculoneuropathy: combined analysis of a large cohort and eleven published series | Q38058926 | ||
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study | Q44954147 | ||
New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients | Q45012826 | ||
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial | Q47419841 | ||
Practical aspects of immunoglobulin replacement | Q47730138 | ||
Childhood chronic inflammatory demyelinating polyneuropathy: an overview of 10 cases in the modern era. | Q48527773 | ||
Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study | Q48954233 | ||
Long-term immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. | Q53646810 | ||
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe | Q55052893 | ||
Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy | Q60678381 | ||
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy | Q73550695 | ||
Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations | Q80357605 | ||
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial | Q80454073 | ||
Child neurology: chronic inflammatory demyelinating polyradiculoneuropathy in children | Q82793767 | ||
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? | Q85464113 | ||
P433 | issue | 1 | |
P921 | main subject | demyelinating polyneuropathy | Q18556682 |
P304 | page(s) | 38-41 | |
P577 | publication date | 2019-01-01 | |
P1433 | published in | Journal of Pediatric Neurosciences | Q6295723 |
P1476 | title | Subcutaneous Immunoglobulin in Infantile Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report | |
P478 | volume | 14 |